ASTRAZEN - Astrazeneca Pharma India

Astrazeneca Pharma India

ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in

Stock Price vs Company Growth

0.3%

3.7%

4.3%

10.8%

13.9%

8.7%

20.2%

10y

21.8%

all

14.2%

🤔 How to analyze this graph?

Last Traded Price

₹ 7,650 0.3%

7,595

9,110

Company Overview

Sales

2,432 Cr

Growth: 25.7%

Profit after Tax

168 Cr

Growth: -9.6%

Mid Cap

19,125 Cr

P/E: 112.7x

Industry P/E: 31.7x

Fundamentals

Sales (Cr)	₹ 2,432
Growth	25.7%
EBITDA	9.5%
P/S	7.9x
Dividend	0.3%
P/E	112.7x
Book Value	₹ 364
PEG Ratio	4.4x
ROE	18.8%
P/B	21.1x

Shareholding Pattern

Institutions

Promoters

Astrazeneca Pharmaceuticals Ab

75.0 %

Others

Tejas Bhalchandra Trivedi

2.67 %

Shivani T. Trivedi

1.98 %

Minaxi Bhalchandra Trivedi

1.84 %

Iepf

0.46 %

Increase Decrease No change

Company Profile Detailed

AstraZeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. The company engages in execution of clinical studies to generate high quality data eligible for submissions to regulatory agencies across the world aimed at developing life altering medical products.

Belongs to (15 Indices) view more

Investors (43)

astra.ph...

all.body...

mansfiel...

Followers (3)

nitin2

keerthi

deepak